Ana Barbas

Oeiras, 2781901, Portugal

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Aldehyde Dehydrogenase 2 (ALDH2): A novel sorafenib target in hepatocellular carcinoma unraveled by the proteome-wide cellular thermal shift assay.

Aldehyde Dehydrogenase 2 (ALDH2): A novel sorafenib target in hepatocellular carcinoma unraveled by the proteome-wide cellular thermal shift assay.

Journal: SLAS discovery : advancing life sciences R & D
Published: December 20, 2023

Novel scFv against Notch Ligand JAG1 Suitable for Development of Cell Therapies toward JAG1-Positive Tumors.

Novel scFv against Notch Ligand JAG1 Suitable for Development of Cell Therapies toward JAG1-Positive Tumors.

Journal: Biomolecules
Published: January 11, 2023

Transcriptome and proteome profiling of activated cardiac fibroblasts supports target prioritization in cardiac fibrosis.

Transcriptome and proteome profiling of activated cardiac fibroblasts supports target prioritization in cardiac fibrosis.

Journal: Frontiers in cardiovascular medicine
Published: August 09, 2022

Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer.

Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer.

Journal: Cancers
Published: June 30, 2021

Development of antibodies against the notch ligand Delta-Like-1 by phage display with activity against breast cancer cells.

Development of antibodies against the notch ligand Delta-Like-1 by phage display with activity against breast cancer cells.

Journal: New biotechnology
Published: August 31, 2020

The Notch ligand DLL1 exerts carcinogenic features in human breast cancer cells.

The Notch ligand DLL1 exerts carcinogenic features in human breast cancer cells.

Journal: PloS one
Published: January 23, 2019

Evaluation of AAV-mediated delivery of shRNA to target basal-like breast cancer genetic vulnerabilities.

Evaluation of AAV-mediated delivery of shRNA to target basal-like breast cancer genetic vulnerabilities.

Journal: Journal of biotechnology
Published: August 01, 2018

Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acids.

Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acids.

Journal: Scientific reports
Published: April 26, 2018

Production and characterization of a novel Delta-like 1 functional unit as a tool for Notch pathway activation and generation of a specific antibody.

Production and characterization of a novel Delta-like 1 functional unit as a tool for Notch pathway activation and generation of a specific antibody.

Journal: Protein expression and purification
Published: November 05, 2017

Notch-out for breast cancer therapies.

Notch-out for breast cancer therapies.

Journal: New biotechnology
Published: October 18, 2016

Retroviral particles are effectively purified on an affinity matrix containing peptides selected by phage-display.

Retroviral particles are effectively purified on an affinity matrix containing peptides selected by phage-display.

Journal: Biotechnology journal
Published: January 26, 2016

Correction: Modulating the RNA Processing and Decay by the Exosome: Altering Rrp44/Dis3 Activity and End-Product.

Correction: Modulating the RNA Processing and Decay by the Exosome: Altering Rrp44/Dis3 Activity and End-Product.

Journal: PloS one
Published: August 22, 2015
Showing 1-12 of 15

Last Updated: 09/26/2026